Physician profile
Kyle Christopher Smith
NPI 1750055695
$1,662.36
in general payments reported to CMS, 2019-2025
12 companies · $435 in 2025
The $435 reported for 2025 was more than what 77% of Surgical providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $14.93 · 2023: $32.32 · 2024: $1,181 · 2025: $435.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,028 · Travel and Lodging: $619.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,028.25 |
| Travel and Lodging | $619.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Terumo Cardiovascular Systems Corporation | $789.10 | 2024 | Virtuosaph Plus With Radial Indication |
| Edwards Lifesciences Corporation | $268.27 | 2024-2025 | Mitris Resilia Mitral Valve, Inspiris Resilia Aortic Valve |
| Atricure, INC. | $266.37 | 2023-2025 | Synergy Ablation System |
| Medical Device Business Services, INC. | $103.96 | 2024 | Vistaseal, Evarrest |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $54.33 | 2025 | Relistor |
| Ethicon US, LLC | $49.05 | 2024 | Vistaseal, Evarrest, Ultra Vac |
| Telix Pharmaceuticals | $48.85 | 2024 | Illuccix |
| Sumitomo Pharma America, INC. | $20.67 | 2025 | Orgovyx |
| Philips North America LLC | $17.59 | 2024 | (Ck4) Mcot |
| Accord Healthcare, INC. | $15.29 | 2024 | |
| Vertos Medical, INC. | $14.93 | 2022 | |
| Tolmar, INC. | $13.95 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kyle Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.